Sarah A. Richman
- Oncology top 5%
- Immunology top 10%
- Molecular Biology
- Biomedical Engineering
- Genetics
- Co-authors
- David M. KranzMichael C. MiloneSelene Nuñez-CruzZissimos P. MourelatosBabak MoghimiZachary T. GershensonLucy Z. LiDavid M. Barrett
- Topics
- CAR-T cell therapy research (10 papers)Virus-based gene therapy research (6 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)
- Cited by
- OncologyImmunologyTransplantation
- Partner nations
- United StatesTaiwan
In The Last Decade
Sarah A. Richman
14 papers receiving 692 citations
Peers
Comparison fields: 5 of 64
- Oncology 502
- Immunology 255
- Molecular Biology 220
- Biomedical Engineering 194
- Genetics 156
Countries citing papers authored by Sarah A. Richman
This map shows the geographic impact of Sarah A. Richman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Richman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Richman more than expected).
Fields of papers citing papers by Sarah A. Richman
This network shows the impact of papers produced by Sarah A. Richman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Richman. The network helps show where Sarah A. Richman may publish in the future.
Co-authorship network of co-authors of Sarah A. Richman
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Richman. A scholar is included among the top collaborators of Sarah A. Richman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Richman. Sarah A. Richman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 69 | |
| 2 | 52 | |
| 3 | 4 | |
| 4 | 76 | |
| 5 | In vivo monitoring of CAR T cells using [18F]fluoropropyl-trimethoprim | 1 |
| 6 | 202 | |
| 7 | 11 | |
| 8 | 44 | |
| 9 | 52 | |
| 10 | 42 | |
| 11 | 22 | |
| 12 | 47 | |
| 13 | 48 | |
| 14 | 32 |
About Sarah A. Richman
Sarah A. Richman is a scholar working on Transplantation, Oncology and Biotechnology, having authored 14 papers that have together received 702 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Virus-based gene therapy research (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Oncology (502 citations), Immunology (255 citations) and Transplantation (23 citations). Sarah A. Richman has collaborated with scholars based in United States and Taiwan. Frequent co-authors include David M. Kranz, Michael C. Milone, Selene Nuñez-Cruz, Zissimos P. Mourelatos, Babak Moghimi, Zachary T. Gershenson, Lucy Z. Li, David M. Barrett, Stephan A. Grupp and Michelle L. Dossett. Their work appears in journals such as Blood, The American Journal of Gastroenterology and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.